Multihance and Ambien drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multihance and Ambien. Common interactions include fibrosis among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people who take Multihance and Ambien have. It is created by eHealthMe based on reports of 91 people who take Multihance and Ambien from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

91 people who take Multihance and Ambien together, and have interactions are studied.


What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,661 Multihance users for its effectiveness, alternative drugs and more.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 89,833 Ambien users for its effectiveness, alternative drugs and more.

Number of Multihance and Ambien reports submitted per year:

Multihance and Ambien drug interactions.

Common Multihance and Ambien drug interactions by gender *:

female:

  1. Fibrosis
  2. Joint stiffness
  3. Muscle spasms
  4. Oedema peripheral
  5. Skin discolouration
  6. Skin hypertrophy
  7. Skin hypopigmentation
  8. Skin induration
  9. Haemangioma of skin
  10. Skin fibrosis

male:

  1. Nephrogenic systemic fibrosis
  2. Pain
  3. Skin induration
  4. Depression
  5. Fibrosis
  6. Musculoskeletal stiffness
  7. Injury
  8. Pain in extremity
  9. Dysstasia
  10. Oedema peripheral

Common Multihance and Ambien drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nephrogenic systemic fibrosis
  2. Axonal neuropathy
  3. Muscle spasms
  4. Myositis
  5. Anxiety
  6. Dry skin
  7. Emotional distress
  8. Extremity contracture
  9. Fibrosis
  10. Injury

40-49:

  1. Abdominal distension
  2. Abdominal pain
  3. Device dislocation
  4. Dysmenorrhoea
  5. Fatigue
  6. Lymphocyte count decreased
  7. Menorrhagia
  8. Migraine
  9. Uterine haemorrhage
  10. Nephrogenic systemic fibrosis

50-59:

  1. Burning sensation
  2. Joint range of motion decreased
  3. Rash macular
  4. Sensory loss
  5. Arthropathy
  6. Cardiac disorder
  7. Dyspnoea
  8. Lichenification
  9. Muscle spasms
  10. Musculoskeletal pain

60+:

  1. Nephrogenic systemic fibrosis
  2. Fibrosis
  3. Pain
  4. Wound
  5. Anhedonia
  6. Emotional distress
  7. Mobility decreased
  8. Muscle contracture
  9. Musculoskeletal stiffness
  10. Oedema peripheral

Common conditions people have *:

  1. Pain: 26 people, 28.57%
  2. Nuclear Magnetic Resonance Imaging Brain: 20 people, 21.98%
  3. Tumor: 8 people, 8.79%
  4. Stress And Anxiety: 8 people, 8.79%
  5. Neoplasm Malignant (cancer tumour): 8 people, 8.79%
  6. Constipation: 8 people, 8.79%
  7. Respiratory Disorder (respiratory disease): 7 people, 7.69%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.69%
  9. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 7 people, 7.69%
  10. Nuclear Magnetic Resonance Imaging Abdominal: 6 people, 6.59%

* Approximation only. Some reports may have incomplete information.

Do you take Multihance and Ambien?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Multihance and Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Multihance side effects:

Browse all side effects of Multihance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ambien side effects:

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Multihance interactions:

Browse all interactions between Multihance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ambien interactions:

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gadobenate dimeglumine and zolpidem tartrate (the active ingredients of Multihance and Ambien, respectively), and Multihance and Ambien (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Multihance and Ambien.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: